MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $438M | $383M | $280M | $286M | $152M | $157M | $232M | $117M | $52M |
| Inventory | $26M | $25M | $22M | $22M | $5.6M | $1.5M | $0 | — | — |
| Current assets | $636M | $550M | $393M | $388M | $190M | $167M | $236M | $119M | $52M |
| Intangible assets | $247M | $261M | $250M | $253M | $59M | $19M | $0 | — | — |
| Total assets | $1.0B | $843M | $671M | $647M | $353M | $295M | $241M | $147M | $52M |
| Current liabilities | $223M | $206M | $127M | $87M | $65M | $43M | $18M | $13M | $2.4M |
| Total liabilities | $1.1B | $528M | $445M | $398M | $211M | $174M | $69M | $16M | $2.4M |
| Shareholders' equity | −$10M | $315M | $226M | $249M | $142M | $120M | $172M | $130M | −$17M |
| Shares outstanding | 64.9M | 60.3M | 49.0M | 47.0M | 38.0M | 31.7M | 30.4M | 25.4M | — |
| Current ratio | 2.86 | 2.67 | 3.10 | 4.45 | 2.94 | 3.91 | 12.80 | 9.13 | 21.22 |